
PB 10 of 2023
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023
I, Nikolai Tsyganov, as delegate for the Minister for Health and Aged Care, make the following determination.
Dated 30 May 2023
Nikolai Tsyganov
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name
2 Commencement
3 Authority
4 Definitions
5 Floor price of certain brands of pharmaceutical items
(1) This instrument is the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023.
(2) This instrument may also be cited as PB 10 of 2023.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 June 2023 | 1 June 2023 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 99ADHC(2) of the National Health Act 1953.
In this instrument:
Act means the National Health Act 1953.
brand has the same meaning as in Part VII of the Act.
pharmaceutical item has the same meaning as in Part VII of the Act.
5 Floor price of certain brands of pharmaceutical items
For the purposes of subsection 99ADHC(2) of the Act, paragraph 99ADHC(1)(c) of the Act applies to a brand of a pharmaceutical item mentioned in column 1 of an item in the following table.
Note: Columns 2, 3 and 4 of the table are included for information only.
Floor price of certain brands of pharmaceutical items | ||||
Item | Column 1 | Column 2 | Column 3 Form | Column 4 Manner of administration |
1 | PKU squeezie | Amino acid formula with vitamins and minerals without phenylalanine | Oral gel 85 g, 30 (PKU squeezie) | Oral |
2 | Cal-500 | Calcium | Tablet, chewable, 500 mg (as carbonate) | Oral |
3
| DBL Desferrioxamine Mesilate | Desferrioxamine | Powder for injection containing desferrioxamine mesilate 2 g | Injection |
4 | Triumeq | Dolutegravir with abacavir and lamivudine | Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg | Oral |
5 | Flucil | Flucloxacillin | Powder for injection 1 g (as sodium monohydrate) | Injection |
6 | Flucil | Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
7 | Flucil | Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
8 | Hymenoptera Honey Bee Venom | Insect allergen extract-honey bee venom | Injection set containing 550 micrograms with diluent | Injection |
9 | Hymenoptera Paper Wasp Venom | Insect allergen extract-paper wasp venom | Injection set containing 550 micrograms with diluent | Injection |
10 | Hymenoptera Yellow Jacket Venom | Insect allergen extract-yellow jacket venom | Injection set containing 550 micrograms with diluent | Injection |
11 | Toujeo Solostar | Insulin glargine | Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection |
12 | Toujeo Solostar | Insulin glargine | Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection |
13 | Lithicarb | Lithium | Tablet containing lithium carbonate 250 mg | Oral |
14 | Quilonum SR | Lithium | Tablet containing lithium carbonate 450 mg (slow release) | Oral |
15 | Lyclear | Permethrin | Cream 50 mg per g, 30 g | Application |
16 | Pro-Cid | Probenecid | Tablet 500 mg | Oral |
17 | PHOSPHATE PHEBRA | Sodium acid phosphate | Tablet, compound effervescent, equivalent to 500 mg phosphorus | Oral |
18 | Lipistart | Triglycerides - medium chain, formula | Oral powder 400 g (Lipistart) | Oral |
19 | K.Quik | Triglycerides, medium chain | Oral liquid 225 mL, 15 (K.Quik) | Oral |